Patents by Inventor John G. Connolly

John G. Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Urinary incontinence device
    Patent number: 6540665
    Abstract: A urinary incontinence device includes an occluding member such as a tampon or plug that is retained by magnetic forces acting between a support and magnetic inserts located adjacent the urethra. The inserts may be implanted or injected and hold the occluding member in place.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: April 1, 2003
    Inventor: John G. Connolly
  • Urinary incontinence device
    Patent number: 6171231
    Abstract: A urinary incontinence device includes an occluding member, such as a tampon or plug that is retained by magnetic forces acting between a support and magnetic inserts located adjacent the urethra. The insets may be implanted or injected and hold the occluding member in place.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: January 9, 2001
    Inventor: John G. Connolly
  • Urinary incontinence device
    Patent number: 5997467
    Abstract: A urinary incontinence device includes an occluding member, such as a tampon or plug, that is retained by magnetic forces acting between a support and magnetic inserts located adjacent the uretha. The inserts may be implanted or injected and hold the occluding member in place.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: December 7, 1999
    Inventor: John G. Connolly
  • Neuronal nicotinic acetylcholine receptor assay
    Patent number: 5591590
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 7, 1997
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman
  • Neuronal nicotinic acetylcholine receptor compositions
    Patent number: 5371188
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 12, 1992
    Date of Patent: December 6, 1994
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann